PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Dillon, MT; Boylan, Z; Smith, D; Guevara, J; Mohammed, K; Peckitt, C; Saunders, M; ... Harrington, KJ; + view all Dillon, MT; Boylan, Z; Smith, D; Guevara, J; Mohammed, K; Peckitt, C; Saunders, M; Banerji, U; Clack, G; Smith, SA; Spicer, JF; Forster, MD; Harrington, KJ; - view fewer (2018) PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours. Clinical and Translational Radiation Oncology , 12 pp. 16-20. 10.1016/j.ctro.2018.06.001 . Green open access

https://ift.tt/2wlYjE4